These seemingly contradictory results can be explained by the study illustrating that HDAC1 has distinct substrates in different breast cancer cell lines, highlighting the effects of tumor heterogeneity on HDAC functions [76]. The gene discussed is HDAC9; the disease is breast carcinoma.